Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 13, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 17, 2026
DirectorIndirect holdingOther
Context
Classification
other
Code P in the derivative table; not an open-market share purchase
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-052827
Filed / recorded
Nov 17, 2026, 9:05 PM UTC
Added to OQRO
Nov 17, 2026, 9:08 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
InspireMD, Inc.
Issuer CIK
1433607
Ticker
NSPR
Reporting person
Paul Stuka
Relationship
Director
Security
Series L Common Stock Warrant
Table
Derivative (Table II)
Transaction date
Nov 13, 2026
Transaction code
P
Shares / units
230,769
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
230,769
Ownership form
Indirect — See Footnote
Amendment
No
Footnotes from the filing
The Series L common stock warrants are immediately exercisable at an exercise price of $0.65 per share and expire on November 16, 2027.
These securities are held by Osiris. The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
5 insiders in a week, 2nd time since 2012Traded Nov 13 · filed 4 days later
An Inspiremd director paid $200K out of pocket for Inspiremd shares. 4 other people at Inspiremd bought some too, in the same month. It was the first purchase in 6 months.
5 insiders in a week, 2nd time since 2012Traded Nov 13 · filed 4 days later
An Inspiremd director paid $50K out of pocket for Inspiremd shares. 4 other people at Inspiremd bought some too, in the same month. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.